发明名称 CANNABINOID RECEPTOR LIGAND
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a compound useful as a cannabinoid receptor ligand, having anti-inflammatory activity and/or immunomodulating activity, and useful in the treatments of various medical conditions. <P>SOLUTION: The compound of the formula I(wherein, n is 0-4; p is 0-4; q is 0-5; and X, Y, Z, R<SP>1</SP>, R<SP>2</SP>, L<SP>1</SP>, L<SP>2</SP>, M<SP>1</SP>and M<SP>2</SP>are each as defined in the Specification), or a pharmaceutically acceptable salt or solvate thereof is provided. <P>COPYRIGHT: (C)2007,JPO&INPIT</p>
申请公布号 JP2007211017(A) 申请公布日期 2007.08.23
申请号 JP20070069642 申请日期 2007.03.16
申请人 SCHERING PLOUGH CORP 发明人 SHANKAR BANDARPALLE B;RIZVI RAZIA K;KOZLOWSKI JOSEPH A;SHIH NENG-YANG
分类号 C07C317/22;A61K31/03;A61K31/085;A61K31/136;A61K31/145;A61K31/341;A61K31/343;A61K31/404;A61K31/4418;A61K31/4439;A61K31/451;A61K31/495;A61K31/505;A61K31/5377;A61P1/04;A61P3/10;A61P11/06;A61P13/12;A61P17/06;A61P19/02;A61P19/10;A61P25/00;A61P27/06;A61P29/00;A61P35/00;A61P37/02;A61P37/08;A61P43/00;C07C317/14;C07C317/36;C07D209/08;C07D209/30;C07D211/54;C07D213/30;C07D213/32;C07D213/38;C07D213/55;C07D213/57;C07D213/71;C07D213/80;C07D213/89;C07D239/26;C07D239/38;C07D295/20;C07D295/205;C07D307/00;C07D307/42;C07D307/64;C07D333/18;C07D333/34;C07D401/04;C07D401/10;C07D401/12;C07D405/04;C07D405/12;C07D493/08 主分类号 C07C317/22
代理机构 代理人
主权项
地址